Skip to main content

FDA Approvals

FDA Approvals
Neratinib First Extended Adjuvant Treatment for Patients with Early-Stage, HER2-Positive Breast Cancer
Read More
FDA Approvals
Blincyto Receives Expanded Indication to Include Patients with Ph+ B-Cell Precursor ALL
Read More
FDA Approvals
Zejula a New Maintenance Treatment Option for Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Read More
Breast Cancer, FDA Approvals, Oncology
Kisqali, a New CDK4/CDK6 Inhibitor, Approved as First-Line Therapy for HR-Positive, HER2-Negative Advanced Breast Cancer
Read More
FDA Approvals, In the News
Nuplazid First Drug Approved for Hallucinations and Delusions Associated with Parkinson’s Disease
Read More
FDA Approvals, In the News
Zynbrita a New Treatment Available for Relapsing Multiple Sclerosis
Read More
FDA Approvals, In the News
FDA Approves First Blood Test to Detect Gene Mutation Associated with Non–Small-Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumors
Read More
FDA Approvals
Atezolizumab First PD-L1 Inhibitor Approved by the FDA for Advanced or Metastatic Urothelial Cancer
Lilly Ostrovsky
Read More
FDA Approvals, In the News
Venclexta FDA Approved for Patients with CLL
Read More
Page 17 of 21
Results 161 - 170 of 205